Etiology and functional status of liver cirrhosis by 31P MR spectroscopy

World Journal of Gastroenterology

Volumn 11, Issue 44, 2005, Pages 6926-6931

  Dezortova, Monika ^a,b   Taimr, Pavel ^b   Skoch, Antonin ^a   Spicak, Julius ^b   Hajek, Milan ^a  

^a MR Unit   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

31P MR spectroscopy; Absolute concentration; Child Pugh score; Etiology; Liver cirrhosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ESTER DERIVATIVE; PHOSPHATE; PHOSPHODIESTER; PHOSPHOMONOESTER; PHOSPHORUS 31; UNCLASSIFIED DRUG;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PATHOGENESIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; VIRUS HEPATITIS;

EID: 31144468983     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i44.6926     Document Type: Article

References (21)

1. Child CG, Turcotte JG. Surgery and portal hypertension. In child CG. The liver and portal hypertension. 1st ed. Philadelphia. WB Saunders Co. 1968: 50-72
2. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
3. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4: 430-435
4. Montgomery Bissel D, Maher JJ. Hepatic fibrosis and cirrhosis. In: Zakim D, Boyer TD. Hepatology, a textbook of liver disease. 4th ed. Philadelphia: Saunders, 2002: 395-416
5. de Graff RA. In vivo NMR Spectroscopy: Principles and Techniques. 1st ed. Chichester: John Wiley & Sons, 1998
6. Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. Radiology 1989; 173: 393-400
7. Munakata T, Griffiths RD, Martin PA, Jenkins SA, Shields R, Edwards RH. An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 1993; 6: 168-172
8. Angus PW, Dixon RM, Rajagopalan B, Ryley NG, Simpson KJ, Peters TJ, Jewell DP, Radda GK. A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. Clin Sci (Lond) 1990; 78: 33-38
9. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995; 21: 417-427
10. Taylor-Robinson SD, Sargentoni J, Bell JD, Saeed N, Changani KK, Davidson BR, Rolles K, Burroughs AK, Hodgson HJ, Foster CS, Cox IJ. In vivo and in vitro he patic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997; 17: 198-209
11. Tosner Z, Dezortova M, Tintera J, Hajek M. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. MAGMA 2001; 13: 40-46
12. Murphy-Boesch J, Jiang H, Stoyanova R, Brown TR. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity. Magn Reson Med 1998; 39: 429-438
13. http://www.statsoft.com/textbook/stathome.html
14. Meloun M, Militky J. Statisticka analyza experimentalnich dat. (Cz) (Statistical analysis of experimental data.) 1st ed. Academia, 2004
15. http://www.eletel.P.lodz.pl/cost/cost_project.html
16. Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M. Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 1998; 16: 205-211
17. Miyamoto K, French SW. Hepatic adenine nucleotide metabolism measured in vivo in rats fed ethanol and a high fat-low protein diet. Hepatology 1988; 8: 53-60
18. Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 2003; 52: 1046-1053
19. Jalan R, Taylor-Robinson SD, Hodgson HJ. In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? J Hepatol 1996; 25: 414-424
20. Kiyono K, Shibata A, Sone S, Watanabe T, Oguchi M, Shikama N, Ichijo T, Kiyosawa K, Sodeyama T. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Acta Radiol 1998; 39: 309-314
21. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003; 37: 788-794